Leptin Protein 26006897 Tender in USA - 147812193

Procurement Summary

Country: USA

Summary: Leptin Protein 26006897

Deadline: 26 Aug 2026

Posting Date: 24 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147812193

Document Ref. No.: 26-006897

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

The National Institute of Health (NIH) intends to negotiate and award a purchase order without
providing for full and open competition to BIO-TECHNE SALES CORP. The purpose of this requirement is to provide a firm-fixed-price contract for Recombinant Rat Leptin Protein in the Critical Care Medicine Department within the NIH Clinical Center.
The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology.
Full-time research activities commence at the beginning of the second year of the fellowship for fellows interested in the critical care subspecialty alone. For those interested in dual board eligibility, their second-year program is individually designed and consists of clinical rotations required for board eligibility in the particular subspecialties. After completion of second subspecialty training, full-time research activities commence. Major topics of research interest within the Department include:
The immunopathogenesis of septic shock
Studies of immune cellular function in respiratory distress syndrome, asthma, and other forms of severe pulmonary disease
Biomarkers and novel therapies in pulmonary arterial hypertension
Biomarkers of acute cellular rejection in heart transplantation
Diagnosis and treatment of opportunistic infections
Studies of immune cellular function and therapy of AIDS
Pathogenesis and treatment of anthrax
Emerging infectious diseases
Biology and clinical effects of nitric oxide
acute lung injury
pulmonary arterial hypertension
role as transcription regulatory factor
Functional genomics of critical illness
human acute inflammation
animal model of septic shock and multiple organ failure
pulmonary arterial hypertension
solid organ transplantation
Emerging Infectious Disease
This product is a sole source item as it-s manufactured by the supplier. This materia...
Notice ID: 26-006897

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health olao

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Inactive Dates: sep 10, 2026

Inactive Policy: 15 days after response date

Disclaimer: The deadline date mentioned is tentative and provided for informational purposes only. This notice is a procurement forecast or general procurement plan, and not an active tender. Suppliers are advised to refer to the original documents and contact the issuing authority directly for the official tender release date and further details

Documents

 Tender Notice

Documents.zip